Brack T, Finckenstein F G, Kabisch H
Abteilung für Hämatologie und Onkologie der Universitäts-Kinderklinik Hamburg.
Klin Padiatr. 1991 Jul-Aug;203(4):323-7. doi: 10.1055/s-2007-1025448.
The analysis of the N-myc gene in bone marrow specimens at the time of initial diagnosis and as well at the time of relapse from patients with Neuroblastoma stage IV and bone marrow infiltration could give some informations about the N-myc status of these patients. In stage IV neuroblastoma patients with bone marrow infiltration an estimation of the N-myc gene amplification should be attempted, if otherwise no information about the tumor content of the N-myc gene could be gathered. In our investigation we could demonstrate a Southern-blot-analysis of 27 bone marrow specimens with respect to the N-myc gene status which correlated qualitatively well to the N-myc amplification detected later on in the corresponding tumor tissue. In six cases the tumor infiltrated bone marrow showed a clear amplification of the N-myc gene. Because of the contamination by non malignant cells in bone marrow there was a quantitative difference in the calculated N-myc gene copies between the examined bone marrow specimens and corresponding tumor tissue.
对IV期神经母细胞瘤且有骨髓浸润的患者在初次诊断时以及复发时的骨髓标本进行N - myc基因分析,可为这些患者的N - myc状态提供一些信息。在有骨髓浸润的IV期神经母细胞瘤患者中,如果无法通过其他方式获取关于肿瘤组织中N - myc基因含量的信息,则应尝试评估N - myc基因扩增情况。在我们的研究中,我们对27份骨髓标本进行了关于N - myc基因状态的Southern印迹分析,其结果在定性上与随后在相应肿瘤组织中检测到的N - myc扩增情况良好相关。在6例病例中,肿瘤浸润的骨髓显示出N - myc基因的明显扩增。由于骨髓中存在非恶性细胞的污染,在所检测的骨髓标本与相应肿瘤组织之间,计算出的N - myc基因拷贝数存在定量差异。